Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Molecular Oncology|January 31, 2017
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancerKaren Hanrahan, Amanda O'Neill, Maria Prencipe, et al.Journal of Clinical Medicine|June 10, 2022
Psychological Interventions in a Pandemic Emergency: A Systematic Review and Meta-Analysis of SARS-CoV-2 StudiesGrazia D'Onofrio, Nicoletta Trotta, Melania Severo, et al.Plos One|December 20, 2012
Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesClaire Corcoran, Sweta Rani, Keith O'Brien, et al.Human Pathology|May 6, 2014
Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancerBarbara McGrogan, Sine Phelan, Patricia Fitzpatrick, et al.Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.Proteomics|May 25, 2012
The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell linesKathleen O'Connell, Maria Prencipe, Amanda O'Neill, et al.The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.The Prostate|November 20, 2013
The analysis of serum response factor expression in bone and soft tissue prostate cancer metastasesGillian O'Hurley, Maria Prencipe, Dara Lundon, et al.The Prostate|January 30, 2013
Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?Maria Prencipe, Stephen F Madden, Amanda O'Neill, et al.Cell Cycle (Georgetown, Tex.)|August 3, 2010
MAD2 downregulation in hypoxia is independent of promoter hypermethylationMaria Prencipe, Aloysius McGoldrick, Antoinette S Perry, et al.Pageof 3